Prognostic Factors for Adverse Outcomes in COVID-19 Infection

J Assoc Physicians India. 2020 Jul;68(7):62-66.


Whilst COVID-19 infection generally run a mild course in up to 80% of those affected, a number of pre-existing co-morbidities determine the severity of infection and the outcome in an individual patient. The most important of these co-morbidities that have consistently emerged in studies from across the globe, are the patients age and sex. Other important co-morbidities that adversely affect outcomes include pre-existing diabetes, obesity, hypertension, chronic lung disease and malignancy. This comprehensive review discusses the impact of these co-morbidities and the role of laboratory predictors of poor patient outcomes.

Publication types

  • Review

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Comorbidity
  • Coronavirus Infections*
  • Humans
  • Pandemics*
  • Pneumonia, Viral*
  • Prognosis
  • SARS-CoV-2